Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk—A Single-Center Cross-Sectional Study

Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis

(2020) Georg Semmler et al.   United European Gastroenterology Journal

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) Is Independently Associated with Cardiovascular Risk in a Large Austrian Screening Cohort

(2020) David Niederseer et al.   Journal of Clinical Medicine

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

(2020) Qing Ye et al.   Lancet Gastroenterology & Hepatology

From NAFLD to MAFLD: Implications of a premature change in terminology

(2020) Zobair M Younossi et al.   HEPATOLOGY

Concordance of MAFLD and NAFLD diagnostic criteria in “real‐world” data

(2020) Giovanni Targher   LIVER INTERNATIONAL

Comparison of MAFLD and NAFLD diagnostic criteria in real world

(2020) Su Lin et al.   LIVER INTERNATIONAL

NASH in Lean Individuals

(2019) Ramy Younes et al.   SEMINARS IN LIVER DISEASE

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

(2019) Pegah Golabi et al.   BMC GASTROENTEROLOGY

The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease

(2019) Yiwen Shi et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific Analysis

(2018) David Niederseer et al.   Journal of Clinical Medicine

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

(2017) Leon A Adams et al.   GUT

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

(2017) Thomas Karlas et al.   JOURNAL OF HEPATOLOGY

Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study

(2017) Ramy Younes et al.   LIVER INTERNATIONAL

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments

(2017) Hironori Kitade et al.   Nutrients

Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population

(2017) Ren-Nan Feng et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver

(2016) Alexandra Feldman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol

(2016) Kuan-Ta Wu et al.   Journal of Clinical Lipidology

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) et al.   European Journal of Preventive Cardiology

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy

(2015) Jeremy Lok Wei et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments

(2014) Akira Sasaki et al.   Frontiers in Endocrinology

Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study

(2013) Chengfu Xu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

(2013) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Prediabetes: a high-risk state for diabetes development

(2012) Adam G Tabák et al.   LANCET

Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

(2012) Zobair M. Younossi et al.   MEDICINE

Ethnic Differences in the Prevalence of Metabolic Syndrome: Results from a Multi-Ethnic Population-Based Survey in Malaysia

(2012) Sanjay Rampal et al.   PLoS One

Ultrasonographically Detected Non-Alcoholic Fatty Liver Disease Is an Independent Predictor for Identifying Patients With Insulin Resistance in Non-Obese, Non-Diabetic Middle-Aged Asian Adults

(2011) Dong Hyun Sinn et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis

(2011) Ruben Hernaez et al.   HEPATOLOGY

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia

(2011) A. Stadlmayr et al.   JOURNAL OF INTERNAL MEDICINE

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

(2010) S. McPherson et al.   GUT

Ethnic differences in body composition and the associated metabolic profile: A comparative study between Asians and Caucasians

(2010) S.N. Wulan et al.   MATURITAS

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

(2009) Srinivasan Dasarathy et al.   JOURNAL OF HEPATOLOGY

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS